Nuzenio

Actimed M

Actimed M news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Actimed regains full control of S-oxprenolol after five-year partnership with Faraday - AllSciAllSci · Thu, 06 Aug 2026 16:48:50 GMTActimed gets back rights to wasting disease drug, ending $126M deal with Faraday - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 12:20:19 GMTActimed retrieves ALS drug after Faraday collapse - European Biotechnology MagazineEuropean Biotechnology Magazine · Thu, 06 Aug 2026 12:13:31 GMTActimed strengthens board with appointment of Dr Anders Ullman - Manufacturing ChemistManufacturing Chemist · Thu, 30 Jul 2026 13:03:34 GMT

Timeline

Thu, 06 Aug 2026 16:48:50 GMTActimed regains full control of S-oxprenolol after five-year partnership with Faraday - AllSci
Thu, 06 Aug 2026 12:20:19 GMTActimed gets back rights to wasting disease drug, ending $126M deal with Faraday - Fierce Biotech
Thu, 06 Aug 2026 12:13:31 GMTActimed retrieves ALS drug after Faraday collapse - European Biotechnology Magazine
Thu, 30 Jul 2026 13:03:34 GMTActimed strengthens board with appointment of Dr Anders Ullman - Manufacturing Chemist

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Actimed M.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.